Clinical experiences with bisphosphonate-induced osteochemonecrosis of the jaws: A new entity for clinicians

Swiss Medical Weekly

Volumn 136, Issue 31-32, 2006, Pages 504-509

  Dannemann, Christine ^a   Gratz K W ^a   Zwahlen, R ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Bisphosphonate; Multidisciplinary treatment; Osteonecrosis of the jaws (ONJ); Supportive cancer treatment prevention

Indexed keywords

ALENDRONIC ACID; ANTIBIOTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CORTICOSTEROID; PAMIDRONIC ACID; ZOLEDRONIC ACID; BONE DENSITY CONSERVATION AGENT;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BONE NECROSIS; BREAST CANCER; CANCER THERAPY; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DECORTICATION; FEMALE; HISTOPATHOLOGY; HUMAN; MALE; MANDIBLE; MAXILLA; MULTIPLE MYELOMA; PROSTATE CANCER; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; JAW DISEASE; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; PROSTATE TUMOR;

ADULT; AGED; BONE DENSITY CONSERVATION AGENTS; BREAST NEOPLASMS; DIPHOSPHONATES; FEMALE; HUMANS; JAW DISEASES; MALE; MIDDLE AGED; MULTIPLE MYELOMA; OSTEONECROSIS; PROSTATIC NEOPLASMS;

EID: 33748778751     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Marx R. Pamidronate (Aredia) and Zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 2003;61:1115-8.
2. Pharma N. Zometa - Fachinformation des Arzneimittelkompendium Schweiz In: Pharma N, ed. Arzneimittelkompendium Schweiz. Basel: Documed AG, 2005.
3. Pharma N. Aredia - Fachinformation des Arzneimittelkompendiums Schweiz In: Ag D, ed. Arzneimittel Kompendium. Basel: Documed AG, 2005.
4. Rogers MJ WD, Russel RGG. Overview of bisphosphonates. Cancer 1997;80:1652-60.
5. Hughes DE WK, Uy HL, Sasaki A, Yoneda T, Roodman GD. Bisphosphonates promote apoptosis in murine osteoclasts in vitro and vivo. J Bone Miner Res 1995;10.
6. Carano A TS, Konsek JD, Schlesinger PH, Blair HC. Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro. J Clin Invest 1990;85:456-61.
7. Bartl R. Bisphosphonate. Manual Supportive Massnahmen und symptomorientierte Therapie. München, 2001;184-90.
8. Van der Pluijm G VH, van Beek E, et al. Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro. J Clin Invest 1996;98:698-705.
9. Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 2004;62:527-34.
10. Bagan JV, Murillo J, Jimenez Y, Poveda R, Milian MA, Sanchis JM, et al. Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 cases. [Review][17 refs. J Oral Pathol Med 2005;34:120-3.
11. Novartis Pharma S. Bisphosphonate und Osteonekrosen des Kiefers. 2005.
12. Tarassof P CK, Novartis Pharma. Avascular necroseis of the jaws: risk factors in metastatic cancer patients. J Oral Maxillofac Surg 2003:1238-9.
13. Hellstein JW, Marek CL. Bisphosphonate osteochemonecrosis (bis-phossy jaw): is this phossy jaw of the 21st century? [Review] [59 refs]. J Oral Maxillofac Surg 2005;63:682-9.
14. Migliorati C. Bisphosphonates and oral cavity avascular bone necrosis. J Clin Oncol 2003;21:4253-4.
15. Migliorati C SM, Douglas E, Seneda L. Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone. An emerging oral complication of supportive cancer therapy. Am Cancer Soc 2005;104:83-93.
16. Assael LA. New foundations in understanding osteonecrosis of the jaws. J Oral Maxillofac Surgery 2004;62:125.
17. Gutteridge DH RR, Ward LC, et al. Bone density changes in Pagets disease 2 years after i.v. pamidonate sustained increases in pagetic bone with severity-related loss in forearm non-pagetic cortical bone. Bone 2003;32:50.
18. Thoma KH. Oral Pathology. 4th ed. St Louis, 1954.
19. Greenberg M. Intravenous bisphosphonates and osteonecrosis [see comment]. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontics 2004W2005;98:259-60.
20. Wang J GN, Pogrel MA. Osteonecrosis of the jaws associated with cancer chemotherapy. J Oral Maxillofac Surg 2003;61:1104-7.
21. Schwartz HC. Osteonecrosis and bisphosphonates: correlation versus causation (comment). J Oral Maxillofac Surg 2004;62:763-4.
22. Lugassey G, S Rea. Severe osteomyelitis of the jaw in long term survivors of multiple myelome: a new clinical entity. Am J Med 2004;117:440-1.
23. Hoefert S EH. Kieferknochennekrosen als mögliche unerwünschte Wirkung von Bisphosphonaten. Mund Kiefer Gesichtschirurg 2005;9:233-8.
24. Melo M OG. Osteonecrosis of the Maxilla in a patient with a history of bisphosphonate therapy. J Canadian Dental Association 2005;71:111-3a.
25. Schirmer IPH, Reichart PA, Dürkop H. Bisphphosphonate und Osteonekrosen im Kieferbereich. Mund Kiefer Gesichtschirurg 2005;9:239-45.